ArticleJournal of translational medicine2023

The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis.

Adrian Georg Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.